Case report: Long-lasting SARS-CoV-2 infection with post-COVID-19 condition in two patients with chronic lymphocytic leukemia: The emerging therapeutic role of casirivimab/imdevimab.
Ballotta L, Simonetti O, D'Agaro P, Segat L, Koncan R, Martinez-Orellana P, Dattola F, Orsini E, Marcello A, Dal Monego S, Licastro D, Misin A, Mohamed S, Sbisà E, Lucchini E, De Sabbata GM, Zaja F, Luzzati R.
Ballotta L, et al. Among authors: luzzati r.
Front Oncol. 2022 Sep 30;12:945060. doi: 10.3389/fonc.2022.945060. eCollection 2022.
Front Oncol. 2022.
PMID: 36249044
Free PMC article.